Subscribe to stay informed!
Castle Creek Pharmaceuticals in New Jersey has reached an agreement to acquire Fibrocell Science, the Exton-based biotechnology company, for $63.3 million, writes John…
Before we send you to this site, please subscribe to our daily newsletter.